Interview by Alexey Bersenev to Dr. Zylberberg-Raw materials, ancillary materials and GMP-grade reagents

Posted on


Claudia Zylberberg is CEO of Akron Biotech, board member of International Society for Cellular Therapy (ISCT) Commercialization Committee and Scientific Advisor of Alliance for Regenerative Medicine (ARM). She kindly agreed to answer my questions for “Not Lost in Translation” series.

http://stemcellassays.com/2013/10/lost-translation-claudia-zylberberg/

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s